Analysis of the effect of ultrasound-guided percutaneous radiofrequency ablation in the treatment of plasma cell mastitis
10.3760/cma.j.cn131148-20240108-00016
- VernacularTitle:超声引导下经皮射频消融治疗浆细胞性乳腺炎的疗效分析
- Author:
Shuo WANG
1
;
Gang DONG
;
Shanshan ZHANG
;
Mengfan PENG
;
Yuang ZHANG
;
Wenwen YUE
;
Zinan ZHAO
Author Information
1. 郑州大学第一附属医院超声科，郑州 450052
- Keywords:
Ultrasound-guided;
Radiofrequency ablation;
Plasma cell mastitis
- From:
Chinese Journal of Ultrasonography
2024;33(6):519-524
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation in the treatment of plasma cell mastitis.Methods:A retrospective analysis was performed for the clinical data of 10 patients with plasma cell mastitis treated with ultrasound-guided percutaneous radiofrequency ablation in the First Affiliated Hospital of Zhengzhou University from January 2021 to December 2022. The postoperative complications, symptoms and signs of the patients, ultrasound imaging manifestations, treatment efficacy at 3 months after surgery, the reduction rate of ablation lesions at 1 month, 3 months, 6 months, and 12 months after surgery, the recurrence status within 1 year after surgery, and the satisfaction with the treatment effect were observed.Results:The reduction rates of ablation lesions at 1 month, 3 months, 6 months, and 12 months were 32.31%-51.00%[(42.78±4.48)%], 70.66%-86.68%[(70.45±12.43)%], 72.31%-100%[(86.91±7.45)%], 89.13%-100%[(96.07±7.45)%], respecctively. The symptoms and signs of 10 patients improved significantly 3 months after surgery, and there was no recurrence of the disease during the follow-up period, and the treatment effect was significant and satisfactory.Conclusions:Ultrasound-guided percutaneous radiofrequency ablation for the treatment of plasma cell mastitis is a minimally invasive, effective and safe treatment.
